CTBS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.150600E-01
Normal-vs-Stage2
7.068800E-01
Normal-vs-Stage3
7.803900E-02
Normal-vs-Stage4
3.684400E-01
Stage1-vs-Stage2
4.663800E-01
Stage1-vs-Stage3
1.031830E-01
Stage1-vs-Stage4
3.698400E-01
Stage2-vs-Stage3
9.662100E-02
Stage2-vs-Stage4
4.340100E-02
Stage3-vs-Stage4
2.397600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.655000E-01
Normal-vs-AfricanAmerican
6.362600E-01
Normal-vs-Asian
5.945800E-01
Caucasian-vs-AfricanAmerican
2.798200E-01
Caucasian-vs-Asian
6.250000E-01
AfricanAmerican-vs-Asian
2.037800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.417200E-01
Normal-vs-Female
9.947600E-01
Male-vs-Female
8.877500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.123400E-01
Normal-vs-Age(41-60Yrs)
7.590400E-01
Normal-vs-Age(61-80Yrs)
6.342800E-01
Normal-vs-Age(81-100Yrs)
2.712400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.641200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.920200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.985400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.857500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.716470E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.892800E-01
Normal-vs-Daily Drinker
3.722200E-01
Normal-vs-Weekly Drinker
4.183600E-01
Normal-vs-Occasional Drinker
5.612800E-01
Normal-vs-Social Drinker
9.881800E-01
Non Drinker-vs-Daily Drinker
8.704600E-01
Non Drinker-vs-Weekly Drinker
9.458600E-01
Non Drinker-vs-Occasional Drinker
8.739800E-03
Non Drinker-vs-Social Drinker
1.598390E-01
Daily Drinker-vs-Weekly Drinker
9.506000E-01
Daily Drinker-vs-Occasional Drinker
9.421000E-03
Daily Drinker-vs-Social Drinker
1.705010E-01
Weekly Drinker-vs-Occasional Drinker
2.853500E-02
Weekly Drinker-vs-Social Drinker
2.376200E-01
Occasional Drinker-vs-Social Drinker
3.173600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.757370E-01
Normal-vs-Grade 2
4.946100E-02
Normal-vs-Grade 3
8.978400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.977600E-01
Grade 1-vs-Grade 3
8.487000E-01
Grade 1-vs-Grade 4
1.757370E-01
Grade 2-vs-Grade 3
7.688400E-01
Grade 2-vs-Grade 4
4.946100E-02
Grade 3-vs-Grade 4
8.978400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.325400E-01
Normal-vs-NonDiabetic
7.186200E-01
Diabetic-vs-NonDiabetic
5.134200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.636160E-01
Normal-vs-NoPancreatitis
7.545000E-01
Pancreatitis-vs-NoPancreatitis
1.610760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.930200E-01
Normal-vs-N1
6.931800E-01
N0-vs-N1
2.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.086600E-01
Normal-vs-TP53-NonMutant
9.994400E-01
TP53-Mutant-vs-TP53-NonMutant
7.233200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
